Cellular and Molecular Defects in Human B Cell Development

Project Details

Description

Relevance: The projects described in this Program Project are based on the study of patients with well-defined genetic immune defects that prevent the producing of antibodies. Patients with these immune defects are prone to serious and recurrent infections, an in some cases, autoimmune diseases. Our studies have the goal of understanding of how humans are efficiently immunized to produce antibodies after vaccination or infection, and how autoimmunity is controlled.
StatusFinished
Effective start/end date15/09/0431/07/22

Funding

  • National Institute of Allergy and Infectious Diseases: $1,416,775.00
  • National Institute of Allergy and Infectious Diseases: $2,125,273.00
  • National Institute of Allergy and Infectious Diseases: $1,924,836.00
  • National Institute of Allergy and Infectious Diseases: $1,525,650.00
  • National Institute of Allergy and Infectious Diseases: $1,999,734.00
  • National Institute of Allergy and Infectious Diseases: $735,485.00
  • National Institute of Allergy and Infectious Diseases: $1,409,196.00
  • National Institute of Allergy and Infectious Diseases: $2,141,918.00
  • National Institute of Allergy and Infectious Diseases: $1,925,282.00
  • National Institute of Allergy and Infectious Diseases: $1,416,286.00
  • National Institute of Allergy and Infectious Diseases: $2,136,538.00
  • National Institute of Allergy and Infectious Diseases: $1,809,366.00
  • National Institute of Allergy and Infectious Diseases: $1,924,821.00
  • National Institute of Allergy and Infectious Diseases: $1,573,400.00
  • National Institute of Allergy and Infectious Diseases: $2,130,985.00
  • National Institute of Allergy and Infectious Diseases: $2,181,897.00
  • National Institute of Allergy and Infectious Diseases: $1,420,556.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.